abstract |
The invention describes new inhibitors of IAP, which are applicable as therapeutic agents for the treatment of malignant tumors, where the compounds have the general formula I in which A, Q, X, X, Y, R, R, R, R, R ', R, R and R 'are as described in the present invention. |